Renaissance Technologies NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is NBIX and the CUSIP is 64125C109. A total of 452 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Renaissance Technologies ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2022$153,204
+8.5%
1,442,464
-0.5%
0.22%
+29.9%
Q2 2022$141,251
+17.7%
1,449,023
+13.2%
0.17%
+18.4%
Q1 2022$120,012
-1.0%
1,280,123
-10.1%
0.14%
-6.6%
Q4 2021$121,253
-6.8%
1,423,664
+5.0%
0.15%
-10.1%
Q3 2021$130,051
+7.5%
1,355,964
+9.1%
0.17%
+11.3%
Q2 2021$120,942
-11.0%
1,242,723
-11.1%
0.15%
-10.7%
Q1 2021$135,942
-21.5%
1,397,864
-22.6%
0.17%
-10.1%
Q4 2020$173,219
-16.2%
1,807,191
-15.9%
0.19%
-8.7%
Q3 2020$206,692
+14.1%
2,149,464
+44.8%
0.21%
+32.1%
Q2 2020$181,141
+190.9%
1,484,764
+106.4%
0.16%
+160.0%
Q1 2020$62,263
-21.6%
719,382
-2.7%
0.06%
-1.6%
Q4 2019$79,454
+22536.5%
739,172
+18853.1%
0.06%
Q3 2019$351
-72.7%
3,900
-74.4%
0.00%
-100.0%
Q2 2019$1,287
-93.6%
15,241
-93.3%
0.00%
-94.4%
Q1 2019$20,082
+270.8%
227,941
+200.6%
0.02%
+200.0%
Q4 2018$5,416
-59.8%
75,841
-53.3%
0.01%
-14.3%
Q2 2018$13,4630.0%162,3410.0%0.01%
-53.3%
Q1 2018$13,463
-55.2%
162,341
-58.1%
0.02%
-54.5%
Q4 2017$30,046
+478.0%
387,241
+196.4%
0.03%
+175.0%
Q3 2015$5,198130,6410.01%